Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    August 2016
  1. FORNARO L, Vasile E, Falcone A
    Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward.
    J Clin Oncol. 2016 Aug 15. pii: JCO686931.
    PubMed     Text format    


  2. LEE HJ, Moon JY, Baek SW
    Is Treatment-Emergent Toxicity a Biomarker of Efficacy of Apatinib in Gastric Cancer?
    J Clin Oncol. 2016 Aug 15. pii: JCO688663.
    PubMed     Text format    


  3. ZHANG S
    Problematic Analysis and Inadequate Toxicity Data in Phase III Apatinib Trial in Gastric Cancer.
    J Clin Oncol. 2016 Aug 15. pii: JCO673889.
    PubMed     Text format    


  4. ZONG L, Abe M, Seto Y, Ji J, et al
    Randomized Controlled Trial of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: How Should We Define the Age of Included Patents?
    J Clin Oncol. 2016 Aug 9. pii: JCO682500.
    PubMed     Text format    


    June 2016
  5. PAVLAKIS N, Sjoquist KM, Martin AJ, Tsobanis E, et al
    Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.
    J Clin Oncol. 2016 Jun 20. pii: JCO651901.
    PubMed     Text format     Abstract available


    May 2016
  6. LI J, Qin S, Xu J, Xiong J, et al
    Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
    J Clin Oncol. 2016;34:1448-54.
    PubMed     Text format     Abstract available


    March 2016
  7. DAL PRA A, Berlin A, Kumareswaran R, Schattner AJ, et al
    Liver Failure After Abdominal Irradiation: Identifying the Right Suspects.
    J Clin Oncol. 2016;34:e80-3.
    PubMed     Text format    


    February 2016
  8. HU Y, Huang C, Sun Y, Su X, et al
    Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.
    J Clin Oncol. 2016 Feb 22. pii: JCO637215.
    PubMed     Text format     Abstract available


  9. SADOWSKI SM, Neychev V, Millo C, Shih J, et al
    Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    J Clin Oncol. 2016;34:588-96.
    PubMed     Text format     Abstract available


  10. ILSON DH
    Targeting the Vascular Endothelial Growth Factor Pathway in Gastric Cancer: A Hit or a Miss?
    J Clin Oncol. 2016 Feb 16. pii: JCO658666.
    PubMed     Text format    


  11. HECHT JR, Bang YJ, Qin SK, Chung HC, et al
    Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
    J Clin Oncol. 2016;34:443-51.
    PubMed     Text format     Abstract available


    January 2016
  12. CANANZI FC, Biondi A, Quagliuolo V, Rausei S, et al
    Chemoradiotherapy in Gastric Cancer: A Door Ajar.
    J Clin Oncol. 2016 Jan 25. pii: JCO609537.
    PubMed     Text format    


    December 2015
  13. JANJIGIAN YY
    Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?
    J Clin Oncol. 2015 Dec 23. pii: JCO642892.
    PubMed     Text format    


    October 2015
  14. SHAH MA, Janjigian YY, Stoller R, Shibata S, et al
    Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.
    J Clin Oncol. 2015 Oct 5. pii: JCO.2015.60.7465.
    PubMed     Text format     Abstract available


  15. ELIMOVA E, Ajani JA
    Surgical Resection First for Localized Gastric Adenocarcinoma: Are There Adjuvant Options?
    J Clin Oncol. 2015;33:3085-91.
    PubMed     Text format     Abstract available


    August 2015
  16. BANG YJ, Im SA, Lee KW, Cho JY, et al
    Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer.
    J Clin Oncol. 2015 Aug 17. pii: JCO.2014.60.0320.
    PubMed     Text format     Abstract available


  17. BURTNESS B
    Complexity in the Gastric Cancer Genome and a Biomarker-Driven Trial of Poly (ADP-Ribose) Polymerase Inhibition in Gastric Cancer.
    J Clin Oncol. 2015 Aug 17. pii: JCO.2015.62.8487.
    PubMed     Text format    


  18. SERRANO C, Wang Y, Marino-Enriquez A, Lee JC, et al
    KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation.
    J Clin Oncol. 2015;33:e93-6.
    PubMed     Text format    


    July 2015
  19. GUIMBAUD R, Louvet C, Ychou M, Bouche O, et al
    Reply to E.C. Smyth et al and E. Elimova et al.
    J Clin Oncol. 2015;33:2410-1.
    PubMed     Text format    


    June 2015
  20. ELIMOVA E, Ajani JA
    Time-to-Treatment Failure As the Primary End Point of a First-Line Advanced Gastric Cancer Randomized Trial: How Confused Would You Want Us to Be?
    J Clin Oncol. 2015 Jun 15. pii: JCO.2014.59.8847.
    PubMed     Text format    


  21. SMYTH EC, Cunningham D
    Epirubicin, Cisplatin, and Capecitabine Versus Fluorouracil, Leucovorin, and Irinotecan for Esophagogastric Cancer: The Original and the Rest.
    J Clin Oncol. 2015 Jun 15. pii: JCO.2014.59.7088.
    PubMed     Text format    


    April 2015
  22. COHEN DJ, Leichman L
    Controversies in the Treatment of Local and Locally Advanced Gastric and Esophageal Cancers.
    J Clin Oncol. 2015 Apr 27. pii: JCO.2014.59.7765.
    PubMed     Text format     Abstract available


  23. SHAH MA
    Update on Metastatic Gastric and Esophageal Cancers.
    J Clin Oncol. 2015 Apr 27. pii: JCO.2014.60.1799.
    PubMed     Text format     Abstract available


    March 2015
  24. TURKINGTON RC, Parkes E, Kennedy RD, Eatock MM, et al
    Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction.
    J Clin Oncol. 2015;33:1088.
    PubMed     Text format    


  25. DAVIES AR, Gossage JA, Zylstra JL, Mattsson F, et al
    Reply to R.C. Turkington et al.
    J Clin Oncol. 2015;33:1089-90.
    PubMed     Text format    


    February 2015
  26. MAHMUD N, Ford JM, Longacre TA, Parent R, et al
    Metastatic lobular breast carcinoma mimicking primary signet ring adenocarcinoma in a patient with a suspected CDH1 mutation.
    J Clin Oncol. 2015;33:e19-21.
    PubMed     Text format    


    January 2015
  27. PARK SH, Sohn TS, Lee J, Lim DH, et al
    Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
    J Clin Oncol. 2015 Jan 5. pii: JCO.2014.58.3930.
    PubMed     Text format     Abstract available


  28. GOODMAN KA
    Refining the Role for Adjuvant Radiotherapy in Gastric Cancer: Risk Stratification Is Key.
    J Clin Oncol. 2015 Jan 5. pii: JCO.2014.59.1941.
    PubMed     Text format    


    November 2014
  29. GUIMBAUD R, Louvet C, Ries P, Ychou M, et al
    Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Federation Francophone de Cancerologie Digestive,
    J Clin Oncol. 2014;32:3520-6.
    PubMed     Text format     Abstract available


    October 2014
  30. KIM HH, Son SY, Ahn S, Han SU, et al
    Reply to M. Honda et al.
    J Clin Oncol. 2014;32:3201-2.
    PubMed     Text format    


  31. HONDA M, Yamamoto K, Furukawa TA
    Retrospective propensity score matching and the selection of surgical procedures: how precise can a propensity estimate be?
    J Clin Oncol. 2014;32:3200-1.
    PubMed     Text format    


    September 2014
  32. HULSHOF MC, Oppedijk V, van der Gaast A
    Reply to E. C. Smyth et al.
    J Clin Oncol. 2014;32:3081-2.
    PubMed     Text format    


  33. DAVIES AR, Gossage JA, Zylstra J, Mattsson F, et al
    Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    J Clin Oncol. 2014;32:2983-90.
    PubMed     Text format     Abstract available


  34. MAMON HJ, Tepper JE
    Reply to E. C. Smyth et al.
    J Clin Oncol. 2014;32:3082.
    PubMed     Text format    


  35. SMYTH EC, Waddell TS, Cunningham D
    Optimal management of esophageal adenocarcinoma: should we be CROSS?
    J Clin Oncol. 2014;32:3080-1.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: